Abstract

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system that is characterized by the presence of demyelinated regions with accumulated myelin lipid debris. Importantly, to allow effective remyelination, such debris must be cleared by microglia. Therefore, the study of microglial activity with sensitive tools is of great interest to better monitor the MS clinical course. Using a boronic acid-based (BASHY) fluorophore, specific for nonpolar lipid aggregates, we aimed to address BASHY’s ability to label nonpolar myelin debris and image myelin clearance in the context of demyelination. Demyelinated ex vivo organotypic cultures (OCSCs) and primary microglia cells were immunostained to evaluate BASHY’s co-localization with myelin debris and also to evaluate BASHY’s specificity for phagocytosing cells. Additionally, mice induced with experimental autoimmune encephalomyelitis (EAE) were injected with BASHY and posteriorly analyzed to evaluate BASHY+ microglia within demyelinated lesions. Indeed, in our in vitro and ex vivo studies, we showed a significant increase in BASHY labeling in demyelinated OCSCs, mostly co-localized with Iba1-expressing amoeboid/phagocytic microglia. Most importantly, BASHY’s presence was also found within demyelinated areas of EAE mice, essentially co-localizing with lesion-associated Iba1+ cells, evidencing BASHY’s potential for the in vivo bioimaging of myelin clearance and myelin-carrying microglia in regions of active demyelination.

Highlights

  • Multiple sclerosis (MS) is the primary chronic demyelinating disease of the central nervous system (CNS) and the leading cause of non-traumatic disability in young adults [1]

  • The photophysical properties

  • This functionally very attractive aspect is ascribed to the push–pull character of boronic acid salicylidenehydrazone complexes (BASHY), which is paired with cyanine-like behavior [30]

Read more

Summary

Introduction

Multiple sclerosis (MS) is the primary chronic demyelinating disease of the central nervous system (CNS) and the leading cause of non-traumatic disability in young adults [1]. Current evidence suggests that MS conditions are closely tied to an immune system dysregulation that leads to myelin sheath degradation into nonpolar lipid fragments within MS-characteristic demyelinated plaques [2]. Continuous demyelination alongside incompetent/inexistent myelin removal causes non-treatable neurodegeneration, which clinically translates into progressive disability at motor, sensitive, and cognitive levels, having severe impacts on the patients’ quality of life [8,9]. Assessing microglial ability to phagocytose myelin with highly sensitive tools is of focal interest to better comprehend, diagnose, and monitor clinical MS conditions and to discover therapeutic approaches that promote disease recovery through remyelination

Objectives
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call